 "Alphabet's AI drug unit Isomorphic Labs raises $600 mn from OpenAI backer")
Isomorphic Labs, the Alphabet Inc.-owned company that uses artificial intelligence to discover drugs, has raised $600 million, the first time it’s taken in external funding.
The round was led by Thrive Capital, with participation from Alphabet and its venture arm, GV, Isomorphic Labs said in a statement Monday. The company’s valuation was not disclosed. Thrive has also invested in OpenAI, a rival to Alphabet’s Google in researching artificial intelligence and bringing to market user-facing products such as chatbots.
Alphabet created Isomorphic Labs in 2021, spinning it out from DeepMind, the AI startup it acquired in 2014. DeepMind’s leader, Demis Hassabis, who runs Google’s AI efforts, is also the chief executive officer of Isomorphic Labs. Last year, the company announced partnerships with Novartis AG and Eli Lilly & Co.
The AI drug discovery company is just the latest Alphabet-owned business to accept outside capital in recent months. Waymo, Alphabet’s autonomous driving unit, closed a $5.6 billion round last October, valuing it at more than $45 billion.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%